Delivery Order SPE2DX22D0049-SPE2D826FA3QD

On January 12, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,305.77 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle valued through December 2031 that serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.

AmerisourceBergen Drug Corp functions as a critical vendor in the federal medical procurement supply chain, supplying prescription medications, generic drugs, specialty pharmaceuticals, vaccines, medical devices, and other healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains, from routine medications to specialized treatments, making it a key participant in sustaining military and federal healthcare operations worldwide.